Overview

Effect of Ketoconazole on Biliary Excretion of AZD0837

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This is an explorative study and the scientific question to be investigated is if the biliary excretion of AZD0837 and its metabolites AR-H069927XX and AR-H067637XX are affected by co-administration with ketoconazole
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ketoconazole